The Brevard-based doctor and former congressman said: "The concern of many people is that big Pharma was behind this, which ...

The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Curevo has set its sights on competing with GSK’s shingles vaccine dominance by securing $110m and securing a former executive from the UK big pharma to advance its candidate amezosvatein.

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.

The Trump administration is canceling studies about ways to improve vaccine trust and access. The move comes in the midst of ...

Seattle, USA-based biotech Curevo Vaccine, which is developing varicella zoster virus (VZV) vaccines with improved tolerability, today announces the closing of a $110 million Series B round to advance ...

Former CDC nominee goes scorched earth, blaming two Republicans and ‘big Pharma’ for failed bid - Weldon’s nomination to head ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff wars, hoping to avert price spikes on top-selling medicines made in Europe ...

Robert F. Kennedy Jr.’s health policies are stirring debate—here’s what they mean for you and the future of healthcare.

Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...